7Baggers
 Lyra Therapeutics Faces Critical Juncture as Challenges Mount  AD HOC NEWS Sat, 15 Nov 2025 08:02:04 GMT
 PERCEPTIVE ADVISORS LLC Reduces Stake in Lyra Therapeutics Inc  GuruFocus Sat, 15 Nov 2025 01:37:21 GMT
 Major Shareholder Sells Thousands of Lyra Therapeutics Shares!  TipRanks Fri, 14 Nov 2025 02:57:34 GMT
 BTIG Maintains Lyra Therapeutics(LYRA.US) With Hold Rating  富途牛牛 Thu, 13 Nov 2025 12:31:00 GMT
 BTIG reiterates Neutral rating on Lyra Therapeutics stock after Q3 results  Investing.com Nigeria Thu, 13 Nov 2025 08:49:23 GMT
 lyra therapeutics, inc. (lyra) reports q3 loss, lags revenue estimates  sharewise.com Thu, 13 Nov 2025 04:55:27 GMT
 Lyra Therapeutics reports Q3 EPS ($3.38), consensus ($4.07)  TipRanks Thu, 13 Nov 2025 01:41:35 GMT
 Lyra Therapeutics, Inc. (LYRA) Reports Q3 Loss, Lags Revenue Estimates  Yahoo Finance Wed, 12 Nov 2025 22:15:02 GMT
 Lyra Therapeutics Narrows Losses And Plots New Drug Trial  Finimize Wed, 12 Nov 2025 21:56:14 GMT
 Lyra Therapeutics Q3 net loss narrows  MarketScreener Wed, 12 Nov 2025 21:25:02 GMT
 Major Shareholder Sells Big Chunk of Lyra Therapeutics Stock!  TipRanks Tue, 11 Nov 2025 03:20:35 GMT
 dentsply international (xray) lags q3 earnings estimates  sharewise.com Thu, 06 Nov 2025 14:15:05 GMT
 published on: 2025-10-29 21:52:23  newser.com Thu, 30 Oct 2025 02:52:23 GMT
 published on: 2025-10-27 05:33:04  newser.com Mon, 27 Oct 2025 10:33:04 GMT

Lyra Therapeutics, Inc
(NASDAQ:LYRA) 

LYRA stock logo

Lyra Therapeutics, Inc., a clinical-stage therapeutics company, focuses on the development and commercialization of novel integrated drug and delivery solutions for the localized treatment of patients with ear, nose, and throat diseases. The company's XTreo technology platform is designed to deliver...

Founded: 2005
Full Time Employees: 33
CEO: Maria Palasis  
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends